The DOI matches its Crossref record; 238 of the 238 references it cites were found in a registry or an index.
Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses
Open accessAbstract
Summary: The immunogenicity of cancer cells is an emerging determinant of anti‐cancer immunotherapy. Beyond developing immunostimulatory regimens like dendritic cell‐based vaccines, immune‐checkpoint blockers, and adoptive T‐cell transfer, investigators are beginning to focus on the immunobiology of dying cancer cells and its relevance for the success of anticancer immunotherapies. It is currently accepted that cancer cells may die in response to anti‐cancer therapies through regulated cell death programs, which may either repress or increase their immunogenic potential. In particular, the induction of immunogenic cancer cell death ( ICD ), which is hallmarked by the emission of damage‐associated molecular patterns (DAMPs); molecules analogous to pathogen‐associated molecular patterns (PAMPs) acting as danger signals/alarmins, is of great relevance in cancer therapy. These ICD ‐associated danger signals favor immunomodulatory responses that lead to tumor‐associated antigens (TAAs)‐directed T‐cell immunity, which paves way for the removal of residual, treatment‐resistant cancer cells. It is also emerging that cancer cells succumbing to ICD can orchestrate “altered‐self mimicry” i.e. mimicry of pathogen defense responses, on the levels of nucleic acids and/or chemokines (resulting in type I interferon/ IFN responses or pathogen response‐like neutrophil activity). In this review, we exhaustively describe the main molecular, immunological, preclinical, and clinical aspects of immunosuppressive cell death or ICD (with respect to apoptosis, necrosis and necroptosis). We also provide an extensive historical background of these fields, with special attention to the self/non‐self and danger models, which have shaped the field of cell death immunology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–238 of 238
DAMP—Induced Allograft and Tumor Rejection: The Circle Is Closing
Land, W. G., Agostinis, P., Gasser, S., Garg, A. D., & Linkermann, A. (2016) · American Journal of Transplantation · doi:10.1111/ajt.14012 · Cited by 85
Self-citationPetrovski, G., Zahuczky, G., Katona, K., Vereb, G., Martinet, W., Nemes, Z., Bursch, W., & Fésüs, L. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402112 · Cited by 81
Zunino, B., Rubio‐Patiño, C., Villa, E., Meynet, O., Proïcs, E., Cornille, A., Pommier, S., Mondragón, L., Chiche, J., Bereder, J. M., et al. (2015) · Oncogene · doi:10.1038/onc.2015.82 · Cited by 79
Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress
Garg, A. D., Maes, H., van Vliet, A. R., & Agostinis, P. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.975089 · Cited by 78
Self-citationHe, Y., Zha, J., Wang, Y., Liu, W., Yang, X., & Yu, P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2704 · Cited by 78
Garg, A. D., Vandenberk, L., Woensel, M. V., Belmans, J., Schaaf, M. B. E., Boon, L., Vleeschouwer, S. D., & Agostinis, P. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1295903 · Cited by 77
Self-citationGregory, C. D., & Brown, S. B. (2005) · Nature Cell Biology · doi:10.1038/ncb1205-1061 · Cited by 75
Lauber, K., Keppeler, H., Munoz, L. E., Koppe, U., Schröder, K., Yamaguchi, H., Krönke, G., Uderhardt, S., Wesselborg, S., Belka, C., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.82 · Cited by 75
Cheng, J., Sun, Y., Zhang, F.-Q., Zhang, X., Qiu, X., Yu, L., Wu, Y., & Ding, C. (2016) · Scientific Reports · doi:10.1038/srep24721 · Cited by 74
Dendritic cell-based therapeutic cancer vaccines: past, present and future
Ahmed, M. S., & Bae, Y. (2014) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2014.3.2.113 · Cited by 73
Colangelo, T., Polcaro, G., Ziccardi, P., Muccillo, L., Galgani, M., Pucci, B., Milone, M. R., Budillon, A., Santopaolo, M., Mazzoccoli, G., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.29 · Cited by 73
Antiviral RNA recognition and assembly by RLR family innate immune sensors
Bruns, A. M., & Horvath, C. M. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.006 · Cited by 69
Suzuki, S., & Kulkarni, A. B. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.112 · Cited by 63
Vandenberk, L., Garg, A. D., Verschuere, T., Koks, C., Belmans, J., Beullens, M., Agostinis, P., Vleeschouwer, S. D., & Gool, S. V. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1083669 · Cited by 61
Self-citationMoghaddam, A. E., Gartlan, K. H., Kong, L., & Sattentau, Q. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003906 · Cited by 60
Garg, A. D., Dudek, A. M., & Agostinis, P. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.372 · Cited by 58
Self-citationInnate immunity at mucosal surfaces: the IRE1-RIDD-RIG-I pathway
Lencer, W. I., Luca, H. E. D., Grey, M. J., & Cho, J. A. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.05.006 · Cited by 55
Siurala, M., Bramante, S., Vassilev, L., Hirvinen, M., Parviainen, S., Tähtinen, S., Guse, K., Cerullo, V., Kanerva, A., Kipar, A., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29048 · Cited by 55
Martin, S., Dudek-Perić, A. M., Maes, H., Garg, A. D., Gabrysiak, M., Demirsoy, S., Swinnen, J. V., & Agostinis, P. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.12.003 · Cited by 54
Self-citationA long non-coding RNA links calreticulin-mediated immunogenic cell removal to RB1 transcription
Musahl, A.-S., Huang, X., Rusakiewicz, S., Ntini, E., Marsico, A., Kroemer, G., Kepp, O., & Ørom, U. A. (2015) · Oncogene · doi:10.1038/onc.2014.424 · Cited by 52
Garg, A. D., Krysko, D. V., Vandenabeele, P., & Agostinis, P. (2016) · Cell Death and Disease · doi:10.1038/cddis.2015.411 · Cited by 52
Self-citationErrington‐Mais, F., Jones, J., Merrick, A. E., Bateman, A., Harrington, K. J., Gough, M. J., O’Donnell, D. M., Selby, P. J., Vile, R. G., & Melcher, A. A. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302609 · Cited by 50
Cao, L., Chang, H., Shi, X., Peng, C., & He, Y. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609331113 · Cited by 48
van Vliet, A. R., Martin, S., Garg, A. D., & Agostinis, P. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.010 · Cited by 44
Self-citationGregory, C. D., & Brown, S. B. (2005) · Nature Cell Biology · doi:10.1038/ncb1205-1161 · Cited by 40
Moserova, I. K., Truxová, I., Garg, A. D., Tomala, J., Agostinis, P., Cartron, P., Vosahlikova, S., Kovář, M., Špíšek, R., & Fucikova, J. P. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1258505 · Cited by 39
Self-citationHong, C., Peng, J., Wei, Y., Peng, H., Hui, Y., Chu-Xiong, Z., Guo-Jian, L., & Guo-Qiang, W. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-177 · Cited by 37
Primary sterile necrotic cells fail to cross-prime CD8+T cells
Gamrekelashvili, J., Ormandy, L. A., Heimesaat, M. M., Kirschning, C. J., Manns, M. P., Korangy, F., & Greten, T. F. (2012) · OncoImmunology · doi:10.4161/onci.21098 · Cited by 36
IRE1α promotes viral infection by conferring resistance to apoptosis
Fink, S. L., Jayewickreme, T., Molony, R. D., Iwawaki, T., Landis, C. S., Lindenbach, B. D., & Iwasaki, A. (2017) · Science Signaling · doi:10.1126/scisignal.aai7814 · Cited by 36
Phylogenetic conservation of the preapoptotic calreticulin exposure pathway from yeast to mammals
Madeo, F., Durchschlag, M., Kepp, O., Panaretakis, T., Zitvogel, L., Fröhlich, K., & Kroemer, G. (2009) · Cell Cycle · doi:10.4161/cc.8.4.7794 · Cited by 33
Yeo, J. G., Leong, J. Y., Arkachaisri, T., Cai, Y., Teo, B. H. D., Tan, J. H., Das, L., & Lu, J. (2016) · Cell Death Discovery · doi:10.1038/cddiscovery.2016.69 · Cited by 31
Bartlett, E. K., Fetsch, P. A., Filie, A. C., Abati, A. D., Steinberg, S. M., Wunderlich, J. R., White, D. E., Stephens, D. J., Marincola, F. M., Rosenberg, S. A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2690 · Cited by 30
Large Scale Comparison of Innate Responses to Viral and Bacterial Pathogens in Mouse and Macaque
Zinman, G., Brower–Sinning, R., Emeche, C. H., Ernst, J., Huang, G. T.-W., Mahony, S., Myers, A. J., O’Dee, D. M., Flynn, J. L., Nau, G. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022401 · Cited by 28
Kötter, B., Frey, B., Winderl, M., Rubner, Y., Scheithauer, H., Sieber, R., Fietkau, R., & Gaipl, U. S. (2015) · Radiation Oncology · doi:10.1186/s13014-015-0506-5 · Cited by 22
Chaurio, R. A., Muñoz, L. E., Maueröder, C., Janko, C., Harrer, T., Fürnrohr, B. G., Niederweis, M., Bilyy, R. O., Schett, G. A., i, M. H., et al. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00560 · Cited by 19
A downside to apoptosis in cancer therapy?
Connell, P. P., & Weichselbaum, R. R. (2011) · Nature Medicine · doi:10.1038/nm0711-780 · Cited by 15
Peter, C., Wesselborg, S., & Lauber, K. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9293-0_3 · Cited by 9
Melphalan, Antimelanoma Immunity, and Inflammation—Response
Garg, A. D., Dudek-Perić, A. M., & Agostinis, P. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-2061 · Cited by 5
Self-citation
Cited by
Ferroptosis, a new form of cell death: opportunities and challenges in cancer
Mou, Y., Wang, J., Wu, J., He, D., Zhang, C., Duan, C., & Li, B. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0720-y · Cited by 1,930
Saxena, M., van der Burg, S. H., Melief, C. J. M., & Bhardwaj, N. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00346-0 · Cited by 1,581
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
Galluzzi, L., Humeau, J., Buqué, A., Zitvogel, L., & Kroemer, G. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0413-z · Cited by 1,349
Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?
Rosales, C. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00113 · Cited by 1,334
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Galluzzi, L., Vitale, I., Warren, S., Adjemian, S., Agostinis, P., Martinez, A. B., Chan, T. A., Coukos, G., Demaria, S., Deutsch, E., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000337 · Cited by 1,119
Self-citation
Metadata
- Authors
- Garg, A. D., & Agostinis, P.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2017-10-13
- Volume
- 280
- Issue
- 1
- Pages
- 126-148
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2762577984
- Cited by
- 440
- References
- 238
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.